\n\n\n\n\t\t\n\t\t\tOmeros\n\t\t\thttp://www.omeros.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tOmeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
Our most...More»
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
Our most clinically advanced product candidates are derived from our proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Our PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.«Less
Overview
\n\t\t\t\tLocation: \tSeattle, WA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tpharmaceutical,\n\t\t\t\tbiopharmaceutical,\n\t\t\t\tcentral nervous system\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series B - $3.1M (01/2009)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tThe Stanley Medical Research Institute\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tTitan Pharmaceuticals\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tNeose Technologies,\n\t\t\t\t\tGenelabs Technologies,\n\t\t\t\t\tTitan Pharmaceuticals,\n\t\t\t\t\tOcera Therapeutics,\n\t\t\t\t\tVerus Pharmaceuticals,\n\t\t\t\t\tPDL BioPharma,\n\t\t\t\t\tComplianceOnline,\n\t\t\t\t\tTobira Pharmaceuticals\n\t\t\t\t
\n\t\t\tRecent News
\n\t\t\t\t\n\t\t\t\t\tOct 8, 2009\n\t\t\t\t\tMistras Up, Omeros Not On IPO Day\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tSep 21, 2009\n\t\t\t\t\tSantander, Verisk, Omeros may make $9 billion IPO week\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tMay 15, 2009\n\t\t\t\t\tMore Musty Old IPOs Resurface\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tJan 28, 2009\n\t\t\t\t\tOmeros Gets $3.1M\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tJan 7, 2009\n\t\t\t\t\tOmeros Scores Research Grant\n\t\t\t\t
\n\t\t\t